← Open Payments lookup

LAURA RICCARDI: Open Payments

NPI 1700581659 · CARNEYS POINT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,499 in 92 payments from 14 companies in 2025. Trend: 2023 $446 · 2024 $1,589 · 2025 $1,499

Food & beverage: $1,499
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.14$263
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$237
Otsuka America Pharmaceutical, Inc.13$202
ABBVIE INC.21$182
Teva Pharmaceuticals USA, Inc.13$160
Janssen Pharmaceuticals, Inc5$124
E.R. Squibb & Sons, L.L.C.5$91
Vanda Pharmaceuticals Inc.4$75
Axsome Therapeutics, Inc.4$72
Almatica Pharma LLC2$31

Products named: INGREZZA, CAPLYTA, VRAYLAR, REXULTI, COBENFY, AUSTEDO XR, INVEGA, UZEDY.

Industry payments across NJ — which companies pay providers there.